Short Stature
33
1
2
21
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.1%
2 terminated out of 33 trials
91.3%
+4.8% vs benchmark
9%
3 trials in Phase 3/4
33%
7 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (33)
Vosoritide for Selected Genetic Causes of Short Stature
Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and Genotype Phenotype Correlation
Oral Manifestations in Egyptian Children With Short Stature
Biological Age in Children With GH Deficiency Undergoing Hormone Replacement Therapy
Short Stature and Psychological Well-being
Testing the Feasibility of a Novel Growth Monitoring Smartphone App
The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children
Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency
Vosoritide for Short Stature in Turner Syndrome
Mauriac Syndrome: Isotopic Techniques and Genetic Analysis
Intervention in Chronic Pediatric Patients and Their Families.
IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 Deficiency
Web-based Adherence Information Integrated Nurse-led Monitoring Clinic
Genetic Causes of Growth Disorders
Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys
Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole
Hypo-mineralization of Primary and Permanent Teeth in a Group of Children With Stunted Growth.A Cross Sectional Study.
Diagnosis of Short Stature in Children : Study of a Cohort of Small-sized Consulting Patients
Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial
Long Term Effects of Nutritional Supplementation on Final Height